Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: dorightbythem	10/1/2025 6:18:44 AM
	Read Replies (1) of 63276

If this is true then there exists a pissing contest that just destroyed over $300 million of company value out of spite. “Tang takes control: Immediately following Tidmarsh's exit, Kevin Tang and another board member stepped in to oversee the company. This reinforced the perception that Tidmarsh was forced out rather than leaving voluntarily. Revenge speculation: For Tidmarsh to later use his powerful position as head of the FDA's Center for Drug Evaluation and Research (CDER) to publicly criticize voclosporin—a drug from a company where Tang is now the chairman and largest shareholder—was seen by many as a highly unusual and potentially retaliatory act. The public clash on LinkedIn served to re-ignite the unresolved tensions from their time together at La Jolla.” How can a public figure make such statements that they know will move the market and not face consequences regardless of whether they are true or false ?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next